Diagnostic and Interventional Cardiology

News | Left Atrial Appendage (LAA) Occluders

Abbott Amplatzer Amulet LAA Occluder Offers Superior Closure Compared to Watchman

August 31, 2021 — Late-breaking data from a head-to-head clinical trial of the Amulet Left Atrial Appendage (LAA) ...

August 31, 2021

Videos | Cardiovascular Information Systems (CVIS)

VIDEO: Cardiology AI Aggregates Patient Data and Enables Interactive Risk Assessments

The vendor MediCardia demonstrated smart software to aggregate cardiology patient data from numerous locations into one ...

August 31, 2021

Through the use of technology, clinicians can better fine-tune department performance, automate documentation for improved reporting accuracy, facilitate compliance with certification programs and regulatory requirements, and ensure contrast dose management across and imaging department or enterprise

Webinar | Radiation Dose Management

Editorial Roundtable Series: Fluoroscopy Dose Optimization

A holistic view of contrast and radiation dose data is imperative to help identify opportunities for clinical and ...

August 27, 2021

Sponsored Content

Cardiovascular Ultrasound Analytics Aids Re-accreditation Process

Feature | Analytics Software

The Benefits of Data Analytics in Clinical Reporting

Accurate reporting is essential to producing the reliable analytics needed to meet lab accreditation standards. This is ...

October 27, 2021

Siemens now seamlessly integrates Epsilon Imaging's strain echo software.

Webinar | Cardiovascular Ultrasound

WEBINAR: Echocardiographic Strain Assessment in a Contemporary Cardiology Practice

This educational webinar is focused on the value echocardiographic strain imaging brings to a contemporary cardiology ...

August 27, 2021

#breakingnews The U.S. Food and Drug Administration (FDA) just granted full approval to the Pfizer/BioNTech Covid-19 vaccine for people age 16 and older. It is the first vaccine to be fully approved by the FDA, and experts say it is expected to open the door for further vaccine mandates.

News | Coronavirus (COVID-19)

Pfizer-BioNTech COVID-19 Vaccine Gets Full Approval from FDA

August 23, 2021 — The U.S. Food and Drug Administration (FDA) just granted full approval to the Pfizer/BioNTech COVID-19 ...

August 23, 2021

An example at HIMSS of deeper third-party software integration in enterprise imaging platforms was Siemens Healthcare showing a new, deep integration with echocardiography strain imaging analysis provider Epsilon Imaging. The integration eliminates the need for a separate login and the Epsilon software is now just a tool option available in the syngo system and it carries over data and images directly into the echo report.

Feature | Information Technology | By Dave Fornell, Editor

Advances in PACS and Cardiology Information Systems at HIMSS 2021

Taking advantage of new technology advances, several radiology PACS, enterprise imaging and cardiovascular information ...

August 20, 2021

Sponsored Content

Feature | Cardiovascular Information Systems (CVIS)

Improving Consistency and Standardization With Structured Reporting

Jeff Rieder M.D., a cardiologist with Coastal Cardiology Charleston, clearly recalls the time when reporting was ...

July 26, 2021

The U.S. Food and Drug Administration (FDA) has granted breakthrough device designation to Abiomed’s new Impella ECP expandable percutaneous heart pump. The designation means the FDA will prioritize Impella ECP’s regulatory review processes including design iterations, clinical study protocols and pre-market approval (PMA) application.

News

FDA Grants Breakthrough Device Designation to Impella ECP

August 20, 2021 – The U.S. Food and Drug Administration (FDA) has granted breakthrough device designation to Abiomed’s ...

August 20, 2021

Gallery | HIMSS | By Dave Fornell, Editor

Photo Gallery of New Technologies at HIMSS 2021

The annual Healthcare Information Management Systems Society (HIMSS) 2021 meeting is the largest health information ...

August 18, 2021

The American Heart Association announced its support this week for the CDC and FDA recommendation that immuno-compromised patients should receive a third dose of the Pfizer or Moderna COVID vaccines. Getty Images #AHA #coronavirus #COVID19

News | Coronavirus (COVID-19) | By Dave Fornell, Editor

American Heart Association Supports COVID Vaccine Boosters Suggested by the CDC

August 18, 2021 — The U.S. Centers for Disease Control and Prevention (CDC) recommended Friday a third dose of the ...

August 18, 2021

Sponsored Content

Case Study | Cardiovascular Information Systems (CVIS)

Mining Cardiology Data to Optimize Patient Care and Improve Productivity

During the COVID-19 pandemic, many cardiology departments were faced with the daunting task of supporting inpatient and ...

June 18, 2021

Videos | Cardiovascular Ultrasound

VIDEO: Examples of Dynamic Blood Flow Imaging in Cardiac Ultrasound

A new ultrasound imaging technology that may offer novel ways to diagnose and better understand cardiac diseases using ...

August 17, 2021

A comparison of color-flow Doppler cardiac ultrasound showing blood flow, and blood speckle tracking revealing a more detailed and complex understanding of the low. It shows the formation of a vortex that may play a role in future assessments for the efficiency of flow in the heart and vessels. #ASE21 #ASE2021 #Vectorflowimaging

Feature | Cardiac Imaging | By Dave Fornell, Editor

Development of Echo Blood Flow Dynamics Imaging

In the past several years, a few cardiac ultrasound vendors have developed new ways to image the intricate flow of ...

August 17, 2021

The Abbott Amplatzer Amulet left atrial appendage (LAA) transcatheter occlusion device. It received FDA clearance in August 2021. #LAA

News | Left Atrial Appendage (LAA) Occluders

FDA Clears Abbott Amplatzer Amulet LAA Occluder to Reduce Stroke in People With Atrial Fibrillation

August 16, 2021 — The U.S. Food and Drug Administration (FDA) approved Abbott's Amplatzer Amulet Left Atrial Appendage ...

August 16, 2021

Sponsored Content

The integration of a cardiovascular information system (CVIS) with electronic medical records (EMR) ensures a seamless flow of data between providers and helps physicians access a more comprehensive picture of a patient’s medical history, leading to better outcomes.

Feature | Cardiovascular Information Systems (CVIS)

Integrating CVIS Data Into the EMR

The integration of a cardiovascular information system (CVIS) with electronic medical records (EMR) ensures a seamless ...

June 15, 2021

A lone vendor booth in a sea of open space in a corner of the expo floor at HIMSS 2021 this week. A large number of vendors decided to pull out of exhibiting at HIMSS in recent weeks because the host city of Las Vegas saw a major surge of COVID cases over July, reaching a 20.2% positivity rate on the day HIMSS began.

Blog | Coronavirus (COVID-19)

HIMSS 2021 Showed What to Expect From In-person Healthcare Conferences During the COVID Pandemic

The in-person 2021 Healthcare Information Management Systems Society (HIMSS) meeting planned for Aug. 9-13 appeared to ...

August 13, 2021

Artificial intelligence is becoming best practice to support clinical decisions and help standardize echocardiography analysis for practices. AI, trained on millions of outcome-based data, can provide automation for operators to obtain highly accurate and precise measurements, to better detect and predict cardiovascular disease.

Webinar | Artificial Intelligence

WEBINAR: Utilization of AI for Echocardiography Analysis and Outcome Prediction

Artificial intelligence is becoming best practice to support clinical decisions and help standardize echocardiography ...

August 12, 2021

Boston Scientific Corp. has commenced enrollment in the HI-PEITHO clinical trial, a collaborative research study with the Pulmonary Embolism Response Team (PERT) Consortium and the University Medical Center of the Johannes Gutenberg University of Mainz comparing use of the EkoSonic Endovascular System in combination with anticoagulation to anticoagulation alone for the treatment of acute, intermediate-high-risk pulmonary embolism (PE).

News | Pulmonary Embolism

Study Compares Interventional Pulmonary Embolism Therapy in Combination With Anticoagulation to Anticoagulation Alone

August 9, 2021 — Boston Scientific Corp. has commenced enrollment in the HI-PEITHO clinical trial, a collaborative ...

August 09, 2021